Home/Filings/4/0000950170-25-004575
4//SEC Filing

SNYDER DAVID S 4

Accession 0000950170-25-004575

CIK 0001835022other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 8:00 AM ET

Size

5.2 KB

Accession

0000950170-25-004575

Insider Transaction Report

Form 4
Period: 2025-01-09
SNYDER DAVID S
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-09+140,562140,562 total
    Exercise: $6.07Exp: 2035-01-09Common Stock, par value $0.0001 per share (140,562 underlying)
Footnotes (1)
  • [F1]The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.

Documents

1 file

Issuer

Coya Therapeutics, Inc.

CIK 0001835022

Entity typeother

Related Parties

1
  • filerCIK 0001398625

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:00 AM ET
Size
5.2 KB